Get started
TopgOptions

NRXP all time low! 2 X Phase 3 clinical trials!

Long
NRX Pharmaceuticals, Inc. (NASDAQ:NRXP)  
TopgOptions  
NASDAQ:NRXP   NRX Pharmaceuticals, Inc.
Trend Analysis Technical Indicators Fundamental Analysis NRXP NRX nrxpharmaceuticals Coronavirus (COVID-19) phase3 buy biotech PHARMA bigpharma
6
0
trendanalysis indicator fundamental nrxp nrx nrxpharmaceuticals coronavirus phase3 buy biotech pharma bigpharma
NRx Pharmaceuticals, Inc. (NRXP) has two Phase III assets for which it has Fast Track and Breakthrough Therapy designation, respectively: intravenous ZYESAMI® for Critical COVID-19 and NRX-101 for bipolar depression with suicidality.

52 Week Range 2.38 - 48.80.
in 2020 the stock was $77.

My price target is 16.50

If this is not the time to buy this stock, then when?!
BUYSELL indicators tradingindicators.store/
TRADING COURSE bit.ly/tradex
Private Signals www.patreon.com/PremiumOptionsSignals
RESULTS www.bit.ly/topgx
1%/DAY: bit.ly/3F56VTW
BYBIT partner.bybit.com/b/37880
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.